Immuron limited

Major-Pharmaceuticals

IMRN


62 Lygon Street
Carlton , VIC 3053

Executive/
Director

Price

  • Last Close
  • $ 2.73
    $ +0.46 20.26 %
    Aug 29, 2024
  • 52-Week High/Low
  • $4.55 - $1.52
  • YTD
  • 39.3%

  • Trading Volume
  • 201
  • Market Cap Full
  • $ 621.9M
  • Shares Outstanding
  • 227.8M
    Jun 30, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - 117.6% 2% -5% -5.8% 34.4% -11.5% 32.1%
Q2 - - 2.9% -11.7% -42.1% 4% -19.2% -36.3% 9.8% 4%
Q3 - - -38.8% -7.6% -13.3% 8% -18.1% -3.3% -4.5% -
Q4 - - 2.3% -39.3% 40% -15% -37% 0.5% 4.8% -
J F M A M J J A S O N D
2024 -4.7% -7.9% 50.6% 5.2% - - - - - - - -
2023 2.4% -10.3% -3.7% 10.9% 0.3% -1.2% -3.5% -4.1% 3.2% -17.6% 34.6% -8.4%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%10%-35%69%-61%-17%-6%39%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - - - - - - -
Q2 - - - - -0.92 -0.45 -1.13 -0.36 -
Q3 - - - - - - - - -
Q4 - - - - - - - - -
A 0 0 0 0 -0.9 -0.5 -1.1 -0.36 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - - - - - -
Jun 142.8 163.2 178.3 227.2 227.8 227.8
Sep - - - - - -
Dec - - - - - -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - 0.8
Fixed Asset Turnover - - - - 0.8
Total Asset Turnover 0.1 - 0.5 0.3 0.2
Leverage
Interest Coverage - - - - -17.4
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Equity multiplier - - - - 0.3